Keith Katkin is a seasoned biopharma executive currently serving as CEO, Chairman, and Board Member across multiple organizations. They have been a Board Member at Syndax Pharmaceuticals since 2017 and have held similar roles at Avanir Pharmaceuticals, CoverMyMeds, and Rigel Pharmaceuticals, among others. Previously, they were the President and CEO of Urovant Sciences from 2017 to 2020 and garnered experience in sales and marketing at notable companies including Amgen and Abbott Laboratories. Katkin holds an advanced degree from the University of California, Los Angeles - The Anderson School of Management, completing their studies in 2000.
Location
Aliso Viejo, United States
This person is not in the org chart
This person is not in any offices